Jiyoon Ryu

1.4k total citations
19 papers, 1.1k citations indexed

About

Jiyoon Ryu is a scholar working on Molecular Biology, Epidemiology and Oncology. According to data from OpenAlex, Jiyoon Ryu has authored 19 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 7 papers in Epidemiology and 6 papers in Oncology. Recurrent topics in Jiyoon Ryu's work include Adipokines, Inflammation, and Metabolic Diseases (7 papers), Bone Metabolism and Diseases (6 papers) and Metabolism, Diabetes, and Cancer (6 papers). Jiyoon Ryu is often cited by papers focused on Adipokines, Inflammation, and Metabolic Diseases (7 papers), Bone Metabolism and Diseases (6 papers) and Metabolism, Diabetes, and Cancer (6 papers). Jiyoon Ryu collaborates with scholars based in United States, South Korea and China. Jiyoon Ryu's co-authors include Hyung Joon Kim, Hong‐Hee Kim, Eun-Ju Chang, Hao Huang, Yoshiko Banno, Lily Dong, Feng Liu, Lijun Zhou, Eun‐Ju Chang and Xuming Mao and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and The EMBO Journal.

In The Last Decade

Jiyoon Ryu

19 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiyoon Ryu United States 15 613 316 253 224 165 19 1.1k
Xiaomin Kang China 17 351 0.6× 209 0.7× 157 0.6× 119 0.5× 164 1.0× 33 901
Per Antonson Sweden 22 783 1.3× 137 0.4× 158 0.6× 229 1.0× 329 2.0× 39 1.5k
Hongling Zhu China 17 380 0.6× 143 0.5× 258 1.0× 166 0.7× 68 0.4× 36 866
Yajun Feng United States 10 537 0.9× 205 0.6× 314 1.2× 110 0.5× 189 1.1× 13 1.1k
Xuechun Xia United States 14 699 1.1× 106 0.3× 201 0.8× 135 0.6× 106 0.6× 22 1.1k
Mari E. Swift United States 8 470 0.8× 90 0.3× 183 0.7× 209 0.9× 155 0.9× 8 985
Shiqiao Ye United States 17 615 1.0× 134 0.4× 76 0.3× 197 0.9× 60 0.4× 44 885
Nadine Watson Australia 9 393 0.6× 274 0.9× 306 1.2× 208 0.9× 133 0.8× 9 970
Ali Nasiri United States 16 466 0.8× 255 0.8× 215 0.8× 113 0.5× 29 0.2× 32 978
Rekha Kar United States 15 792 1.3× 135 0.4× 146 0.6× 139 0.6× 54 0.3× 23 1.1k

Countries citing papers authored by Jiyoon Ryu

Since Specialization
Citations

This map shows the geographic impact of Jiyoon Ryu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiyoon Ryu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiyoon Ryu more than expected).

Fields of papers citing papers by Jiyoon Ryu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiyoon Ryu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiyoon Ryu. The network helps show where Jiyoon Ryu may publish in the future.

Co-authorship network of co-authors of Jiyoon Ryu

This figure shows the co-authorship network connecting the top 25 collaborators of Jiyoon Ryu. A scholar is included among the top collaborators of Jiyoon Ryu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiyoon Ryu. Jiyoon Ryu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Ryu, Jiyoon, M. Smith, Juli Bai, et al.. (2024). Diet-enhanced LRG1 expression promotes insulin hypersecretion and ER stress in pancreatic beta cells. Diabetologia. 68(3). 615–628. 2 indexed citations
2.
Xiao, Yang, Yanfei Wang, Jiyoon Ryu, et al.. (2023). Upregulated TGF-β1 contributes to hyperglycaemia in type 2 diabetes by potentiating glucagon signalling. Diabetologia. 66(6). 1142–1155. 15 indexed citations
3.
Ryu, Jiyoon, Soo Jeong, Young‐Jae Cho, et al.. (2022). Combination effect of poly (ADP-ribose) polymerase inhibitor and DNA demethylating agents for treatment of epithelial ovarian cancer. Gynecologic Oncology. 165(2). 270–280. 7 indexed citations
4.
Ryu, Jiyoon, Zhi Li, Feng Dong, et al.. (2021). Adiponectin Alleviates Diet-Induced Inflammation in the Liver by Suppressing MCP-1 Expression and Macrophage Infiltration. Diabetes. 70(6). 1303–1316. 35 indexed citations
5.
Ryu, Jiyoon, Huan Xu, Min Zhou, et al.. (2019). Potential Roles of Adiponectin Isoforms in Human Obesity with Delayed Wound Healing. Cells. 8(10). 1134–1134. 14 indexed citations
6.
Ryu, Jiyoon, Kun Dong, Yang Xiao, et al.. (2018). Alternative splicing variant of the scaffold protein APPL1 suppresses hepatic adiponectin signaling and function. Journal of Biological Chemistry. 293(16). 6064–6074. 11 indexed citations
7.
Ryu, Jiyoon, Xiaoban Xin, Feng Dong, et al.. (2014). APPL1 Potentiates Insulin Sensitivity by Facilitating the Binding of IRS1/2 to the Insulin Receptor. Cell Reports. 7(4). 1227–1238. 104 indexed citations
8.
Wang, Chen, Xiaowen Li, Kaida Mu, et al.. (2013). Deficiency of APPL1 in mice impairs glucose-stimulated insulin secretion through inhibition of pancreatic beta cell mitochondrial function. Diabetologia. 56(9). 1999–2009. 20 indexed citations
9.
Piccio, Laura, Claudia Cantoni, Daniel Hawiger, et al.. (2013). Lack of adiponectin leads to increased lymphocyte activation and increased disease severity in a mouse model of multiple sclerosis. European Journal of Immunology. 43(8). 2089–2100. 82 indexed citations
10.
Kikani, Chintan K., Jiyoon Ryu, Yanying Shen, et al.. (2012). Proliferative and Antiapoptotic Signaling Stimulated by Nuclear-Localized PDK1 Results in Oncogenesis. Science Signaling. 5(249). ra80–ra80. 23 indexed citations
11.
Deepa, Sathyaseelan S., Lijun Zhou, Jiyoon Ryu, et al.. (2011). APPL1 Mediates Adiponectin-Induced LKB1 Cytosolic Localization Through the PP2A-PKCζ Signaling Pathway. Molecular Endocrinology. 25(10). 1773–1785. 62 indexed citations
12.
Ryu, Jiyoon, Hyunsoo Kim, Eun‐Ju Chang, et al.. (2010). Proteomic analysis of osteoclast lipid rafts: the role of the integrity of lipid rafts on V-ATPase activity in osteoclasts. Journal of Bone and Mineral Metabolism. 28(4). 410–417. 16 indexed citations
13.
Zhou, Lijun, Sathyaseelan S. Deepa, Jiyoon Ryu, et al.. (2009). Adiponectin Activates AMP-activated Protein Kinase in Muscle Cells via APPL1/LKB1-dependent and Phospholipase C/Ca2+/Ca2+/Calmodulin-dependent Protein Kinase Kinase-dependent Pathways. Journal of Biological Chemistry. 284(33). 22426–22435. 178 indexed citations
14.
Chang, Eun‐Ju, Jeongim Ha, Frank Oerlemans, et al.. (2008). Brain-type creatine kinase has a crucial role in osteoclast-mediated bone resorption. Nature Medicine. 14(9). 966–972. 94 indexed citations
15.
Kim, Hyung Joon, Youngkyun Lee, Eun‐Ju Chang, et al.. (2007). Suppression of Osteoclastogenesis by N,N-Dimethyl-D-erythro-sphingosine: A Sphingosine Kinase Inhibition-Independent Action. Molecular Pharmacology. 72(2). 418–428. 37 indexed citations
16.
Ryu, Jiyoon, Hyung Joon Kim, Eun-Ju Chang, et al.. (2006). Sphingosine 1‐phosphate as a regulator of osteoclast differentiation and osteoclast–osteoblast coupling. The EMBO Journal. 25(24). 5840–5851. 244 indexed citations
17.
Chang, Eun‐Ju, Hyon J. Kim, Jeongim Ha, et al.. (2006). Hyaluronan inhibits osteoclast differentiation via Toll-like receptor 4. Journal of Cell Science. 120(1). 166–176. 96 indexed citations
18.
Ryu, Jiyoon, et al.. (2005). Proteomic identification of the TRAF6 regulation of vacuolar ATPase for osteoclast function. PROTEOMICS. 5(16). 4152–4160. 11 indexed citations
19.
Jeong, Ji Hoon, Jung‐Sun Kim, Byeong Chun Lee, et al.. (2005). Influence of exposure to electromagnetic field on the cardiovascular system. Autonomic and Autacoid Pharmacology. 25(1). 17–23. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026